[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100306705":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":34,"centralContacts":38,"locations":44,"responsibleParty":64,"collaborators":67,"id":70,"slug":71,"hasResults":72,"nctId":73,"briefTitle":74,"officialTitle":75,"acronym":33,"eligibilityCriteria":76,"healthyVolunteers":72,"sex":77,"minAge":78,"maxAge":33,"enrollmentInfo":79,"targetDuration":33,"studyType":82,"phases":83,"briefSummary":85,"conditions":86,"keywords":88,"overallStatus":47,"whyStopped":33,"lastUpdateSubmitDate":92,"lastUpdatePostDateStruct":93,"startDateStruct":96,"completionDateStruct":98,"leadSponsor":100,"locationsCount":101},{"fullName":5,"class":6},"University of Saskatchewan","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Ketamine (HIKER)","EXPERIMENTAL","Patients in the HIKER arm will receive a single dose of ketamine 0.50 mg\u002Fkg, which is enough to achieve a full anaesthetic effect (i.e., unconsciousness mimicking the GA regimen above), on 8 successive weekdays.",[13],"Drug: Ketamine",{"label":15,"type":16,"description":17,"interventionNames":18},"Ketamine-ECT (EAST)","ACTIVE_COMPARATOR","Patients in the EAST arm will initially receive intravenous ketamine 0.75 mg\u002Fkg, remifentanil 1 mcg\u002Fkg (to reduce discomfort), and succinylcholine 0.75 mg\u002Fkg (for safety). Based on patients' anaesthetic response, the attending anaesthesiologist is given the freedom to vary the dose of remifentanil and succinylcholine as well as administer propofol to achieve safe and acceptable anaesthetic conditions. As per the Saskatoon Health Region's care standard, patients in the EAST arm will receive eight ECT sessions (on a bi\u002Ftriweekly schedule) delivered by the attending psychiatrist with either unilateral or bilateral electrode placement and monitoring of seizure threshold by the half-age method.",[13,19],"Procedure: ECT",[21,28],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DRUG","Ketamine","IV Ketamine 0.50 mg\u002Fkg",[9,15],[27],"Ketalar",{"type":29,"name":30,"description":31,"armGroupLabels":32,"otherNames":33},"PROCEDURE","ECT","ECT with unilateral or bilateral electrode placement and monitoring of seizure threshold by the half-age method",[15],null,[35],{"name":36,"affiliation":5,"role":37},"Jonathan Gamble, MD","PRINCIPAL_INVESTIGATOR",[39],{"name":40,"role":41,"phone":42,"phoneExt":33,"email":43},"Una Goncin","CONTACT","3066551183","ung039@usask.ca",[45],{"facility":46,"status":47,"city":48,"state":49,"zip":50,"country":51,"countryCode":52,"cosmosGeoPoint":53,"geoPoint":58,"contacts":59},"Royal University Hospital","RECRUITING","Saskatoon","Saskatchewan","S7N 0W8","Canada","CA",{"type":54,"coordinates":55},"Point",[56,57],-106.66892,52.13238,{"lat":57,"lon":56},[60],{"name":61,"role":41,"phone":62,"phoneExt":33,"email":63},"Stephen Lee, MD","3065010928","stl960@mail.usask.ca",{"type":37,"investigatorFullName":65,"investigatorTitle":66,"investigatorAffiliation":5,"oldNameTitle":33,"oldOrganization":33},"Jonathan Gamble","M.D.",[68],{"name":69,"class":6},"Royal University Hospital Foundation","100306705","phase-4-ect-with-ketamine-anesthesia-vs-high-intensity-ketamine-with-ect-rescue-for-treatment-resistant-depression-100306705",false,"NCT03272698","ECT with Ketamine Anesthesia Vs High Intensity Ketamine with ECT Rescue for Treatment-Resistant Depression","A Prospective Randomized Controlled Trial of Electroconvulsive Therapy with Ketamine Anesthesia (Standard Therapy) and High Intensity Ketamine with Electroconvulsive Therapy Rescue for Treatment-Resistant Depression - EAST HIKER Trial","Inclusion Criteria:\n\n* Montgomery Asberg Depression Rating Scale (MADRS) score of greater than 20) planned for ECT therapy.\n* Subjects must meet clinical criteria for TRD defined as failure to respond to at least 2 standard-of-care drug therapies of adequate treatment duration.\n\nExclusion Criteria:\n\n* Subjects will be ineligible if they cannot provide informed consent\n* American Society of Anesthesiology physical status score of four or greater\n* Implanted medical device with electronic parts (e.g. pacemaker, defibrillator, intrathecal pump, spinal cord stimulator, deep brain stimulator)\n* Schizoaffective disorder\n* Women of child-bearing potential will be asked to undergo a commercial urine pregnancy screening test. Those who refuse or screen positive will be excluded.\n* Allergic to any of the study drugs or their carrier components\n* Any serious physical condition prior to randomization deemed by the attending psychiatrist or consulting anesthetist to be a contraindication to ECT such as cardiovascular disease (including untreated hypertension), respiratory disease, cerebrovascular disease, intracranial hypertension (including glaucoma), or seizures.","ALL","18 Years",{"count":80,"type":81},62,"ESTIMATED","INTERVENTIONAL",[84],"PHASE4","To determine if an high intensity ketamine with ECT rescue (HIKER) approach for treatment resistant depression will: 1) reduce patient suffering by hastening disease remission, 2) have fewer side effects, 3) reduce the need for ECT, and 4) be preferred by most patients. Half of participants will be randomized to the HIKER arm and receive high intensity ketamine treatment for eight consecutive days, and the other half will be assigned to the ECT with ketamine anesthesia (EAST) arm and receive 8 ECT treatments (2-3 treatment\u002Fweek)",[87,23],"Treatment Resistant Depression",[89,90,91],"ketamine","treatment-resistant depression","electroconvulsive therapy","2025-01-20",{"date":94,"type":95},"2025-01-23","ACTUAL",{"date":97,"type":95},"2017-09-01",{"date":99,"type":81},"2025-12-31",{"name":5,"class":6},1]